[go: up one dir, main page]

ATE91304T1 - Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe. - Google Patents

Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe.

Info

Publication number
ATE91304T1
ATE91304T1 AT88301382T AT88301382T ATE91304T1 AT E91304 T1 ATE91304 T1 AT E91304T1 AT 88301382 T AT88301382 T AT 88301382T AT 88301382 T AT88301382 T AT 88301382T AT E91304 T1 ATE91304 T1 AT E91304T1
Authority
AT
Austria
Prior art keywords
antigen
yeast
shepatitis
pres
procedure
Prior art date
Application number
AT88301382T
Other languages
English (en)
Inventor
Shigeko Yamazaki
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE91304T1 publication Critical patent/ATE91304T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT88301382T 1987-02-27 1988-02-18 Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe. ATE91304T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1982087A 1987-02-27 1987-02-27
EP88301382A EP0280470B1 (de) 1987-02-27 1988-02-18 Verfahren zur Herstellung des pres 1/S2/S-Hepatitis-B-Antigens aus Hefe

Publications (1)

Publication Number Publication Date
ATE91304T1 true ATE91304T1 (de) 1993-07-15

Family

ID=21795203

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88301382T ATE91304T1 (de) 1987-02-27 1988-02-18 Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe.

Country Status (5)

Country Link
EP (1) EP0280470B1 (de)
JP (1) JPS63270628A (de)
AT (1) ATE91304T1 (de)
DE (1) DE3882154T2 (de)
DK (1) DK100888A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2043808T3 (es) * 1987-03-09 1994-01-01 Merck & Co Inc Purificacion de antigeno superficial de hepatitis b recombinante.
EP0314240A3 (de) * 1987-10-26 1990-03-28 Merck & Co. Inc. Verfahren für de Reinigung von rekombinanten Hepatitis-Antigenen
US5011915A (en) * 1987-10-26 1991-04-30 Merck & Co., Inc. Process for purifying recombinant hepatitis antigens
JPH0216975A (ja) * 1988-02-09 1990-01-19 Eugene Tech Internatl Inc 異成分混交性のプレーｓに富んだｂ型肝炎表面抗原
IL99025A0 (en) * 1990-08-15 1992-07-15 Astra Ab Novel process for the detection of pathogens using dna probes
CU22290A1 (es) * 1990-10-08 1995-01-31 Cigb Procedimiento para la obtencion de antigeno de superficie del virus de la hepatitis b de superior capacidad inmunoganica y su uso en un preparado vacunal
US5102989A (en) * 1991-03-15 1992-04-07 Merck & Co., Inc. Method of stabilizing recombinant hepatitis B virus surface proteins from recombinant host cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76274B (de) * 1981-08-04 1984-08-04 Univ California
KR850001534A (ko) * 1983-08-22 1985-03-30 제임스 에프. 나우톤 형질전환된 효모로 부터 유도된 면역원성 HBsAg
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate
JPS63501121A (ja) * 1985-08-15 1988-04-28 アムジエン 酵母細胞からｂ型肝炎表面抗原を抽出するための細胞溶解法および緩衝液
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen

Also Published As

Publication number Publication date
DK100888D0 (da) 1988-02-26
DE3882154D1 (de) 1993-08-12
EP0280470A1 (de) 1988-08-31
EP0280470B1 (de) 1993-07-07
JPS63270628A (ja) 1988-11-08
DE3882154T2 (de) 1993-12-02
DK100888A (da) 1988-10-28

Similar Documents

Publication Publication Date Title
DE68929115D1 (de) Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe
ATE170630T1 (de) Proteine mit geänderten epitopen und verfahren zur deren herstellung
DE69210645D1 (de) Verfahren zur Herstellung von cysteinfreien Peptiden
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
DE69110663D1 (de) Verfahren zur herstellung eines enzymhydrolysates.
ATE123780T1 (de) Verfahren zur verwendung und herstellung von peptiden.
FI884993A0 (fi) Polypeptider.
NO872988D0 (no) Pattedyr-interleukin-4.
ES8104412A1 (es) Procedimiento para la preparacion de un hidrolizado de pro- teinas purificado.
ATE73298T1 (de) Verfahren zum erhalt von konzentraten aus molke, die einen hohen alpha-lactalbumingehalt haben.
ATE132904T1 (de) Verfahren zur herstellung von trehalulose und isomaltulose
DE59107901D1 (de) Verfahren zur herstellung gereinigter glycolipide durch membrantrennverfahren
ATE166881T1 (de) Verfahren zur herstellung von faktor viii
ATE91304T1 (de) Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe.
DE69024105D1 (de) Verfahren zur Herstellung von gereinigten Albuminlösungen
AT384032B (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
DE3574269D1 (en) Apparatus for the separation of products from a product-substrate mixture
ATE82471T1 (de) Verfahren zur abtrennung bestimmter proteine aus molke.
ATE76082T1 (de) Reinigungsmethode fuer antikoerper.
DK412389D0 (da) Fremgangsmaade til udvinding af oprenset epi protein fra en fermenteringsoploesning
DK628188A (da) Protein og fremgangsmaade til fremstilling deraf
ATE110112T1 (de) Verfahren und systeme zur herstellung von hiv- antigenen.
NO843750L (no) Immuninterferon og fremgangsmaate ved fremstilling derav
ATE91303T1 (de) Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen.
ATE106894T1 (de) Verfahren zur herstellung von protease- inhibitoren.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee